Prolytix Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
Prolytix General Information
Description
Operator of a contract research organization (CRO) intended for the biopharma industry. The company provides research reagents, customized blood collection tubes, as well as protein biochemistry services, including assay development, validation, and stability testing, thereby providing clients with complete services from discovery to Good Manufacturing Practice (GMP) release of large-molecule therapeutics.
Contact Information
Website
www.goprolytix.com(Operating Subsidiary)
Corporate Office
- 57 River Road
- Suite 1021
- Essex Junction, VT 05452
- United States
Corporate Office
- 57 River Road
- Suite 1021
- Essex Junction, VT 05452
- United States
Prolytix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Prolytix Comparisons
Industry
Financing
Details
Prolytix Competitors (15)
One of Prolytix’s 15 competitors is Harvard Bioscience, a Formerly PE-Backed company based in Holliston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Harvard Bioscience | Formerly PE-Backed | Holliston, MA | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| Rockland (Pennsylvania) | Private Equity-Backed | Limerick, PA | ||||
| Enzo Biochem | Private Equity-Backed | Farmingdale, NY | ||||
| R&D Systems | Corporate Backed or Acquired | Minneapolis, MN |
Prolytix Patents
Prolytix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20060148022-A1 | And blood-coagulation factor vii using aminonapthalene sulfonamide-based fluorogenic substrates | Active | 13-Nov-2002 | ||
| US-7604932-B2 | And blood-coagulation factor vii using aminonapthalene sulfonamide-based fluorogenic substrates | Inactive | 13-Nov-2002 | ||
| AU-2003290663-A1 | Assay for tissue factor and factor viia | Inactive | 13-Nov-2002 | ||
| AU-2003290663-A8 | Assay for tissue factor and factor viia | Inactive | 13-Nov-2002 | ||
| WO-2004043991-A2 | Assay for tissue factor and factor viia | Inactive | 13-Nov-2002 | C12Q1/37 |
Prolytix Signals
Prolytix Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Prolytix FAQs
-
When was Prolytix founded?
Prolytix was founded in 1987.
-
Where is Prolytix headquartered?
Prolytix is headquartered in Essex Junction, VT.
-
What is the size of Prolytix?
Prolytix has 50 total employees.
-
What industry is Prolytix in?
Prolytix’s primary industry is BPO/Outsource Services.
-
Is Prolytix a private or public company?
Prolytix is a Private company.
-
What is Prolytix’s current revenue?
The current revenue for Prolytix is .
-
Who are Prolytix’s investors?
Edgewater Capital Partners and Fidus Capital have invested in Prolytix.
-
Who are Prolytix’s competitors?
Harvard Bioscience, Novus Biologicals, Rockland (Pennsylvania), Enzo Biochem, and R&D Systems are some of the 15 competitors of Prolytix.
-
When was Prolytix acquired?
Prolytix was acquired on 03-Sep-2026.
-
Who acquired Prolytix?
Prolytix was acquired by VION Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process